Omar Mamlouk

7PUBLICATIONS
19CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 17, 2025
Nilotinib-Induced Unilateral Renal Artery Stenosis: A Complication Prompting Treatment-Free Remission in Chronic Myeloid Leukemia.

Mitchell C Boshkos, Humberto R Nieves-Jiménez, Parin H Thakkar

|Nov 14, 2023
Infliximab for Treatment of Immune Adverse Events and Its Impact on Tumor Response.

Vishnupriyadevi Parvathareddy, Umut Selamet, Aditi A Sen

|Oct 12, 2023
Real-world analysis of safety and efficacy of CAR T-cell therapy in lymphoma patients with decreased kidney function.

Omar Mamlouk, Paolo Strati, Lei Feng

|Oct 09, 2021
Acute kidney injury in patients treated with immune checkpoint inhibitors.

Shruti Gupta, Samuel A P Short, Meghan E Sise

|Jan 29, 2021
Safety of CAR T-cell therapy in kidney transplant recipients.

Omar Mamlouk, Ranjit Nair, Swaminathan P Iyer

|Oct 06, 2020
Immune checkpoint inhibitor associated reactivation of primary membranous nephropathy responsive to rituximab.

Jamie S Lin, Daniel Y Wang, Omar Mamlouk

Pageof 2

Frequent Collaborators

3 joint publications

Jamie S Lin

2 joint publications

Ala Abudayyeh

2 joint publications

Raphael E Steiner

2 joint publications

Sairah Ahmed